Infection and Evidence-Based Medicine in Immunocompromised Populations
Affiliated HospitalPeking Union Medical College Hospital, Chinese Academy of Medical Sciences
→
Research areas: Diagnosis and differential diagnosis of febrile diseases, diagnosis and treatment of various infectious diseases (especially hepatitis, tuberculosis, and complicated infections), and selection and application of antibacterial drugs.
Cutting-edge technology: Pioneered the focus in China on the high risk of tuberculosis in patients with rheumatic and immunological diseases, leading a multicenter cross-sectional study investigating the prevalence of active tuberculosis in Chinese patients with rheumatic and immunological diseases and analyzing risk factors, published in Q1 journal. Led the development of multiple expert consensus statements on tuberculosis prevention and management, winning the second prize of Beijing Science and Technology Progress Award in 2020.
Diseases of expertise: Diagnosis and differential diagnosis of febrile diseases, tuberculosis, hepatitis, and complicated infections.
Academic Highlights and Core Values: Chief Physician and Professor of Infectious Diseases. He holds a leading national position in infection control among immunocompromised populations and has promoted the standardization of tuberculosis risk management for patients with rheumatic and immunological diseases in China.